Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactavip is a standardized herbal galactagogue and maternal recovery supplement developed by Royal Medicalink Pharmalab. It is formulated as an oral capsule containing a combination of *Sauropus androgynus* (Katuk leaf) extract, *Trigonella foenum-graecum* (Fenugreek) extract, and *Channa striata* (snakehead fish) bio-albumin peptides. Lactavip is designed for nursing mothers to stimulate the production of prolactin and oxytocin, thereby enhancing breast milk volume and nutrient density. Additionally, the bio-albumin component supports postpartum recovery by accelerating the healing of perineal and cesarean section incisions and restoring maternal physical stamina.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lactavip.